Lessons learned from randomised clinical trials in adult low grade glioma.

"Lesson" is a Middle English word that has been defined as "a passage from sacred writings read in a service of worship" as well as "something learned by study or experience". The term is quite appropriate in assessment of what has been learned from randomised trials in adult low-grade gliomas, since the treatment of these tumours has traditionally been guided as much by belief as by fact. Therefore, when assessing these trials we can apply the principles of hermeneutics. Thus, the first meaning of "lesson" given here can be described as literal, whereas the second may be seen as figurative. Since hermeneutics may also refer to an in-depth analysis of a particular text, the investigators will present their interpretation of data from randomised trials. The goal is to show that the lessons learned are not necessarily literal or dogmatic but can be much more allegorical in nature.

[1]  E. Shaw,et al.  Central Nervous System Tumors , 2006 .

[2]  M. Berger,et al.  Low-grade hemispheric gliomas in adults: a critical review of extent of resection as a factor influencing outcome. , 2001, Journal of neurosurgery.

[3]  Neurocognitive function after radiotherapy (RT) for supratentorial low-grade gliomas (LGG): results of a north central cancer treatment group (NCCTG) prospective study , 2003 .

[4]  B. Scheithauer,et al.  Effects of radiotherapy on cognitive function in patients with low-grade glioma measured by the folstein mini-mental state examination. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  P E Ricci,et al.  Imaging of low- and intermediate-grade gliomas. , 2001, Seminars in radiation oncology.

[6]  D. Kondziolka,et al.  Survival after stereotactic biopsy and irradiation of cerebral nonanaplastic, nonpilocytic astrocytoma. , 1995, Journal of neurosurgery.

[7]  Philippe Cornu,et al.  Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis. , 2002, International journal of radiation oncology, biology, physics.

[8]  A. Karim,et al.  A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844. , 1996, International journal of radiation oncology, biology, physics.

[9]  B. Scheithauer,et al.  Adult patients with supratentorial pilocytic astrocytomas: a prospective multicenter clinical trial. , 2004, International journal of radiation oncology, biology, physics.

[10]  F. Davis,et al.  Trends in incidence of primary brain tumors in the United States, 1985-1994. , 2001, Neuro-oncology.

[11]  M. Folstein,et al.  Univariate and Multivariate Analyses of the Mental Status Examination , 1985 .

[12]  B. Scheithauer,et al.  Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  Desmond Curran,et al.  Quality of life after radiation therapy of cerebral low-grade gliomas of the adult: results of a randomised Phase III trial on dose response (EORTC trial 22844) , 1998 .

[14]  K. Skullerud,et al.  Survival, prognostic factors, and therapeutic efficacy in low-grade glioma: a retrospective study in 379 patients. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  B. Scheithauer,et al.  Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  R. Stupp,et al.  Promises and controversies in the management of low-grade glioma. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[17]  K. Hess,et al.  Multifaceted end points in brain tumor clinical trials: cognitive deterioration precedes MRI progression. , 2003, Neuro-oncology.

[18]  E. Shaw,et al.  Current controversies in the radiotherapeutic management of adult low-grade glioma. , 2004, Seminars in oncology.

[19]  H. Engler,et al.  Positron emission tomography 11C‐methionine and survival in patients with low‐grade gliomas , 2001 .

[20]  M. Berger,et al.  The effect of extent of resection on recurrence in patients with low grade cerebral hemisphere gliomas , 1994, Cancer.

[21]  B. Fisher,et al.  Supratentorial low-grade glioma in adults: an analysis of prognostic factors and timing of radiation. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  C. Daumas-Duport,et al.  Radiation therapy in the management of low-grade supratentorial astrocytomas. , 1989, Journal of neurosurgery.

[23]  B. Scheithauer,et al.  Phase II trial of procarbazine, lomustine, and vincristine as initial therapy for patients with low-grade oligodendroglioma or oligoastrocytoma: efficacy and associations with chromosomal abnormalities. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  B. Fisher,et al.  Pretreatment factors predict overall survival for patients with low-grade glioma: a recursive partitioning analysis. , 1999, International journal of radiation oncology, biology, physics.

[25]  J. Jolles,et al.  Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study , 2002, The Lancet.

[26]  J. Crowley,et al.  A randomized trial of radiotherapy versus radiotherapy plus CCNU for incompletely resected low-grade gliomas: a Southwest Oncology Group study. , 1993, Journal of neurosurgery.

[27]  A. Karim,et al.  Prognostic factors for survival in adult patients with cerebral low-grade glioma. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  R. Stupp,et al.  Current and Future Trials of the EORTC Brain Tumor Group , 2004, Oncology Research and Treatment.

[29]  John C. Roeske,et al.  Intensity Modulated Radiation Therapy: A Clinical Perspective , 2005 .